Tembexa
Total Payments
$45,325
Transactions
5
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $45,325 | 5 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $45,325 | 5 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TMBX | Emergent BioSolutions Inc. | $45,325 | 1 |
Top Doctors Receiving Payments for Tembexa
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pediatrics | Madera, CA | $45,325 | 5 |
Ad
Manufacturing Companies
- Emergent BioSolutions Inc. $45,325
Product Information
- Type Drug
- Total Payments $45,325
- Total Doctors 1
- Transactions 5
About Tembexa
Tembexa is a drug associated with $45,325 in payments to 1 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Emergent BioSolutions Inc..
Payment data is available from 2023 to 2023. In 2023, $45,325 was paid across 5 transactions to 1 doctors.
The most common payment nature for Tembexa is "Unspecified" ($45,325, 100.0% of total).
Tembexa is associated with 1 research study, including "TMBX" ($45,325).